From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.

Mitchell J, Neitzke-Spruill L, Mathai DS, Robinson JO, Kavan Z, Averil LA, McGuire AL

Open source

DOI
10.1093/tbm/ibag027
Published
2026 Jan 7
Container
Translational behavioral medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/tbm/ibag027,
  title = {From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.},
  author = {Mitchell J and Neitzke-Spruill L and Mathai DS and Robinson JO and Kavan Z and Averil LA and McGuire AL},
  year = {2026},
  journal = {Translational behavioral medicine},
  doi = {10.1093/tbm/ibag027},
  url = {https://doi.org/10.1093/tbm/ibag027}
}

RIS

TY  - JOUR
TI  - From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.
AU  - Mitchell J
AU  - Neitzke-Spruill L
AU  - Mathai DS
AU  - Robinson JO
AU  - Kavan Z
AU  - Averil LA
AU  - McGuire AL
PY  - 2026
JO  - Translational behavioral medicine
DO  - 10.1093/tbm/ibag027
UR  - https://doi.org/10.1093/tbm/ibag027
ER  - 

APA

J, M., L, N., DS, M., JO, R., Z, K., LA, A., & AL, M. (2026). From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.. Translational behavioral medicine. https://doi.org/10.1093/tbm/ibag027

Source records